APA

Schuler E., Zadrozny N., Blum S., Schroeder T., Strupp C., Hildebrandt B., Kündgen A., Gattermann N., Aul C., Kondakci M., Kobbe G., Haas R. & Germing U. (20181105). Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy. : Annals of hematology.

Chicago

Schuler Esther, Zadrozny Natalie, Blum Sabine, Schroeder Thomas, Strupp Corinna, Hildebrandt Barbara, Kündgen Andrea, Gattermann Norbert, Aul Carlo, Kondakci Mustafa, Kobbe Guido, Haas Rainer and Germing Ulrich. 20181105. Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy. : Annals of hematology.

Harvard

Schuler E., Zadrozny N., Blum S., Schroeder T., Strupp C., Hildebrandt B., Kündgen A., Gattermann N., Aul C., Kondakci M., Kobbe G., Haas R. and Germing U. (20181105). Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy. : Annals of hematology.

MLA

Schuler Esther, Zadrozny Natalie, Blum Sabine, Schroeder Thomas, Strupp Corinna, Hildebrandt Barbara, Kündgen Andrea, Gattermann Norbert, Aul Carlo, Kondakci Mustafa, Kobbe Guido, Haas Rainer and Germing Ulrich. Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy. : Annals of hematology. 20181105.